Company / Current Assets
INOVIO PHARMACEUTICALS, INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$61.1M
FY2025
5-year range
$61.1M / $448.4M
FY2021-FY2025
Trend
-37.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 5 consecutive years, from $471M in FY2020 to $61M in FY2025.
Based on SEC 10-K filings.
$61M in FY2025 with a 5-year CAGR of -33.5%.
Declined from $153M to $61M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -42.1%
- 5-Year CAGR
- -33.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- INOVIO PHARMACEUTICALS, INC.'s current assets has declined for 5 consecutive years.
- 5-year CAGR of -33.5%, indicating a declining trend.
- In FY2025, current assets decreased 37.5% year-over-year.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $61.1M | -37.5% |
| FY2024 | $97.8M | -36.1% |
| FY2023 | $153.1M | -51.4% |
| FY2022 | $315.2M | -29.7% |
| FY2021 | $448.4M | -4.8% |
| FY2020 | $471.2M | +400.2% |
| FY2019 | $94.2M | +7.3% |
| FY2018 | $87.8M | -36.5% |
| FY2017 | $138.4M | +11.0% |
| FY2016 | $124.6M | -27.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026